VKTX
Viking Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$27.41
+5.05%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-106.6%
Return on equity
-64.2%
Return on assets
-76.9%
Return on invested capital
0.00x
Asset turnover
-$462.6M
Cash from operations
$7.53
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026